Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

5-MeO-EiPT

This article is a stubmissing:
Subjective Effects
Pharmacology
Interactions
Tolerance
History & Culture
5-MeO-EiPT molecule structure5-MeO-EiPT molecule structure
Chemical Class
Tryptamine

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold1-3 mg
Light3-7 mg
Moderate7-15 mg
Strong15-20 mg
Heavy20+ mg

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacology not written up yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Toxicity

thermoregulatory/autonomic

Sweating and chills are listed among negative effects, and rodent studies reported hypothermia.

musculoskeletal

Muscle tension is listed among negative effects.

central nervous system

Confusion and insomnia are listed among negative effects, and rodent studies reported hypolocomotion.

History & Culture

History & Culture not written up yet

Legality

By Country

Illegal1
Japan flagJapanIllegal

References

Citations

  1. 指定薬物名称・構造式一覧（令和8年8月27日現在）. mhlw.go.jp (n.d.). https://www.mhlw.go.jp/content/11120000/001743040.pdf1
  2. 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律第二条第十五項に規定する指定薬物及び同法第七十六条の四に規定する医療等の用途を定める省令 第一条第七十三号. laws.e-gov.go.jp (n.d.). https://laws.e-gov.go.jp/api/2/law_data/419M60000100014?elm=MainProvision-Article_1-Paragraph_1-Item_731
  3. 平成２０年度無承認無許可医薬品等買上調査の結果について. mhlw.go.jp (n.d.). https://www.mhlw.go.jp/houdou/2009/08/h0820-2.html1
  4. 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律 第七十六条の四. laws.e-gov.go.jp (n.d.). https://laws.e-gov.go.jp/api/1/articles;lawNum=%E6%98%AD%E5%92%8C%E4%B8%89%E5%8D%81%E4%BA%94%E5%B9%B4%E6%B3%95%E5%BE%8B%E7%AC%AC%E7%99%BE%E5%9B%9B%E5%8D%81%E4%BA%94%E5%8F%B7;article=%E7%AC%AC%E4%B8%83%E5%8D%81%E5%85%AD%E6%9D%A1%E3%81%AE%E5%9B%9B1

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the 5-MeO-EiPT article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.